BioPharma
New UK Biotech Centres To Boost Cell And Gene Therapies
The National Health Service Blood and Transplant from the UK, which takes care of blood as well as platelet donations as well as organ, stem cell, and tissue transplants in the country, has come up with a new clinical...
Clinical Trials
$15m Mitochondrial Clinical Trial Headed by Australian University
Almost 50 children in Australia are born every year with a devastating mitochondrial disease that has an expected lifespan of just 5 years. In a first in Australia, the Medical Research Future Fund has gone on to announce $15...
Drug Research
Immune System Can Get Bacteria Assistance To Thwart Tumors
The introduction of bacteria to a tumor’s microenvironment goes on to create the possibility of acute inflammation, which further triggers the immune system’s primary responder cells to attack rather than just protect the tumor, as per the researchers at...
Clinical Trials
Intracranial Pressure Reduced Through Injectable Peptide
It has come to light that patient with idiopathic intracranial hypertension- IIH can be treated with an injectable peptide used for type 2 diabetes. This has been found in a Phase II trial. As per the study’s latest findings,...
News
4 Essentials Of A Quality Clinical Trial Database Build
A quality clinical trial database is an essential part of any clinical trial. It helps to address challenges such as inaccurate data, lack of quality data, and managing the trial timeline. A well-built database also helps improve collaboration between...
News
What is the Medicare Part D coverage gap?
Breaking Down the Medicare Part D Coverage Gap: What You Need to Know
Medicare Part D is a prescription drug benefit program for individuals who are eligible for Medicare, which is a federal health insurance program for people who are...
News
Biocytogen Announces RenLite Licensing Agreement with Janssen
Biocytogen Pharmaceuticals announced the signing of a non-exclusive license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Under the agreement, Biocytogen grants Janssen and its affiliates a non-exclusive worldwide license to use...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















